{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T11:46:05Z","timestamp":1784547965105,"version":"3.55.0"},"reference-count":58,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","journals.elsevierhealth.com","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Nutrition"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.clnu.2019.01.006","type":"journal-article","created":{"date-parts":[[2019,1,16]],"date-time":"2019-01-16T21:53:46Z","timestamp":1547675626000},"page":"49-56","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Vitamin B complex supplementation as a homocysteine-lowering therapy for early stage diabetic nephropathy in pediatric patients with type 1 diabetes: A randomized controlled trial"],"prefix":"10.1016","volume":"39","author":[{"given":"Nancy Samir","family":"Elbarbary","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eman Abdel Rahman","family":"Ismail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mamdouh Ahmed","family":"Zaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasser Wagih","family":"Darwish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marwa Zaki","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manal","family":"El-Hamamsy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clnu.2019.01.006_bib1","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/nrneph.2011.51","article-title":"Inflammatory\u00a0molecules and pathways in the pathogenesis of diabetic nephropathy","volume":"7","author":"Navarro-Gonz\u00e1lez","year":"2011","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.clnu.2019.01.006_bib2","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.2337\/diabetes.52.8.2110","article-title":"Prevention of incipient diabetic nephropathy by high-dose thiamine and benfotiamine","volume":"52","author":"Babaei-Jadidi","year":"2003","journal-title":"Diabetes"},{"key":"10.1016\/j.clnu.2019.01.006_bib3","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0065-2423(01)35015-1","article-title":"Cystatin C \u2013 properties and use as a diagnostic marker","volume":"35","author":"Grubb","year":"2000","journal-title":"Adv Clin Chem"},{"key":"10.1016\/j.clnu.2019.01.006_bib4","first-page":"BC09","article-title":"Association between serum cystatin C and creatinine in chronic kidney disease subjects attending a tertiary health care centre","volume":"11","author":"DSa","year":"2017","journal-title":"J\u00a0Clin Diagn Res"},{"key":"10.1016\/j.clnu.2019.01.006_bib5","first-page":"e229","article-title":"Clinical significance of cystatin C in acute coronary syndromes: something more than a marker of renal function?","volume":"1","author":"Mariani","year":"2014","journal-title":"Inflamm cell signal"},{"key":"10.1016\/j.clnu.2019.01.006_bib6","first-page":"1908","article-title":"Renin-angiotensin-aldosterone system blockade in diabetic nephropathy. Present evidences","volume":"4","author":"Lozano-Maneiro","year":"2015","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.clnu.2019.01.006_bib7","doi-asserted-by":"crossref","first-page":"54","DOI":"10.2174\/1871530314666141111103217","article-title":"Vitamins and type 2 diabetes mellitus","volume":"15","author":"Vald\u00e9s-Ramos","year":"2015","journal-title":"Endocr Metab Immune Disord - Drug Targets"},{"key":"10.1016\/j.clnu.2019.01.006_bib8","doi-asserted-by":"crossref","first-page":"528","DOI":"10.3122\/jabfm.2009.05.090044","article-title":"The prevalence of vitamin B12 deficiency in patients with type 2 diabetes: a cross sectional study","volume":"22","author":"Pflipsen","year":"2009","journal-title":"J\u00a0Am Board Fam Med"},{"issue":"1","key":"10.1016\/j.clnu.2019.01.006_bib9","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/2251-6581-12-17","article-title":"Vitamin B12 deficiency among patients with diabetes mellitus: is routine screening and supplementation justified?","volume":"12","author":"Kibirige","year":"2013","journal-title":"J\u00a0Diabetes Metab Disord"},{"key":"10.1016\/j.clnu.2019.01.006_bib10","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1007\/s00125-007-0771-4","article-title":"High prevalence of low plasma thiamine concentration in diabetes linked to marker of vascular disease","volume":"50","author":"Thornalley","year":"2007","journal-title":"Diabetologia"},{"key":"10.1016\/j.clnu.2019.01.006_bib11","first-page":"951","article-title":"Blood thiamine and its phosphate esters as measured by high-performance liquid chromatography: levels and associations in diabetes mellitus patients with varying degrees of microalbuminuria","volume":"35","author":"Al-Atta","year":"2012","journal-title":"J\u00a0Endocrinol Invest"},{"key":"10.1016\/j.clnu.2019.01.006_bib12","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.diabres.2014.09.058","article-title":"Vitamin B status in patients with type 2 diabetes mellitus with and without incipient nephropathy","volume":"107","author":"Nix","year":"2015","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.clnu.2019.01.006_bib13","first-page":"297","article-title":"Plasma homocysteine and microvascular complications in type 1 diabetes","volume":"10","author":"Vaccaro","year":"2000","journal-title":"Nutr Metabol Cardiovasc Dis: Nutr Metabol Cardiovasc Dis"},{"key":"10.1016\/j.clnu.2019.01.006_bib14","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1007\/s00125-002-0908-4","article-title":"Total plasma homocysteine is associated with hypertension in Type I diabetic patients","volume":"45","author":"Neugebauer","year":"2002","journal-title":"Diabetologia"},{"key":"10.1016\/j.clnu.2019.01.006_bib15","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1007\/s00125-003-1104-x","article-title":"Homocysteine as a risk factor for nephropathy and retinopathy in Type 2 diabetes","volume":"46","author":"Looker","year":"2003","journal-title":"Diabetologia"},{"key":"10.1016\/j.clnu.2019.01.006_bib16","first-page":"12529","article-title":"Association of homocysteine with type 1 diabetes mellitus: a meta-analysis","volume":"8","author":"Feng","year":"2015","journal-title":"Int J Clin Exp Med"},{"key":"10.1016\/j.clnu.2019.01.006_bib17","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1590\/S1516-89132013000300007","article-title":"The effect of melatonin and\/or complex vitamin B1,B6, B12 in modulating epinephrine-induced stress in male rats","volume":"56","author":"EL-Toweissy","year":"2013","journal-title":"Braz Arch Biol Technol"},{"key":"10.1016\/j.clnu.2019.01.006_bib18","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1001\/jama.2010.490","article-title":"Effect of B-vitamin therapy on progression of diabetic nephropathy: a randomized controlled trial","volume":"303","author":"House","year":"2010","journal-title":"J\u00a0Am Med Assoc"},{"key":"10.1016\/j.clnu.2019.01.006_bib19","first-page":"216","article-title":"Vitamin supplements in type 2 diabetes mellitus management: a review. Diabetes Metab Syndrome","volume":"28","author":"Yan","year":"2017","journal-title":"Clin Res Rev"},{"key":"10.1016\/j.clnu.2019.01.006_bib20","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1046\/j.1523-1755.2002.00207.x","article-title":"Pyridoxamine inhibits early renal disease and dyslipidemia in the streptozotocin-diabetic rat","volume":"61","author":"Degenhardt","year":"2002","journal-title":"Kidney Int"},{"key":"10.1016\/j.clnu.2019.01.006_bib21","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1007\/s00125-004-1582-5","article-title":"High-dose thiamine therapy counters dyslipidaemia in streptozotocin-induced diabetic rats","volume":"47","author":"Babaei-Jadidi","year":"2004","journal-title":"Diabetologia"},{"key":"10.1016\/j.clnu.2019.01.006_bib22","doi-asserted-by":"crossref","first-page":"726","DOI":"10.7326\/0003-4819-152-11-201006010-00232","article-title":"CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials","volume":"152","author":"Schulz","year":"2010","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.clnu.2019.01.006_bib23","first-page":"S50","article-title":"Standards of medical care in diabetes-2015","volume":"38","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/j.clnu.2019.01.006_bib24","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.2337\/diacare.24.9.1560","article-title":"Does microalbuminuria predict diabetic nephropathy?","volume":"24","author":"Tabaei","year":"2001","journal-title":"Diabetes Care"},{"key":"10.1016\/j.clnu.2019.01.006_bib25","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.2337\/diacare.27.2007.S79","article-title":"American diabetes association. Nephropathy in diabetes","volume":"27","author":"Molitch","year":"2004","journal-title":"Diabetes Care"},{"issue":"Suppl 27","key":"10.1016\/j.clnu.2019.01.006_bib26","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/pedi.12742","article-title":"ISPAD clinical practice consensus guidelines 2018: microvascular and macrovascular complications in children and adolescents","volume":"19","author":"Donaghue","year":"2018","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/j.clnu.2019.01.006_bib27","doi-asserted-by":"crossref","first-page":"3821","DOI":"10.2337\/dc13-2042","article-title":"Nutrition therapy recommendations for the management of adults with diabetes","volume":"36","author":"Evert","year":"2013","journal-title":"Diabetes Care"},{"issue":"Suppl 20","key":"10.1016\/j.clnu.2019.01.006_bib28","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/pedi.12175","article-title":"International society for pediatric and adolescent diabetes. ISPAD clinical practice consensus guidelines 2014. Nutritional management in children and adolescents with diabetes","volume":"15","author":"Smart","year":"2014","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/j.clnu.2019.01.006_bib29","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000180580","article-title":"Prediction of creatinine clearance from serum creatinine","volume":"16","author":"Cockcroft","year":"1976","journal-title":"Nephron"},{"key":"10.1016\/j.clnu.2019.01.006_bib30","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1046\/j.1523-1755.2003.00208.x","article-title":"Predicting GFR in children and adults: a comparison of the Cockcroft-Gault, Schwartz, and modification of diet in renal disease formulas","volume":"64","author":"Pierrat","year":"2003","journal-title":"Kidney Int"},{"key":"10.1016\/j.clnu.2019.01.006_bib31","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1007\/s00125-009-1334-7","article-title":"Thiamine in diabetic nephropathy\u202f: a novel treatment modality\u202f? Reply to Alkhalaf A, Kleefstra N, Groenier KH","volume":"52","author":"Rabbani","year":"2009","journal-title":"Diabetologia"},{"key":"10.1016\/j.clnu.2019.01.006_bib32","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.jpba.2010.11.008","article-title":"Effect of high dose thiamine on the levels of urinary protein biomarkers in diabetes mellitus type 2","volume":"54","author":"Riaz","year":"2011","journal-title":"J\u00a0Pharmaceut Biomed Anal"},{"key":"10.1016\/j.clnu.2019.01.006_bib33","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/j.1524-4733.2007.00213.x","article-title":"Medication compliance and persistence: terminology and definitions","volume":"11","author":"Cramer","year":"2008","journal-title":"Value Health"},{"key":"10.1016\/j.clnu.2019.01.006_bib34","first-page":"719","article-title":"Reference range of total serum homocysteine level and dietary indexes in healthy Greek schoolchildren aged 6-15 years","volume":"96","author":"Papandreou","year":"2006","journal-title":"Br J Nutr"},{"key":"10.1016\/j.clnu.2019.01.006_bib35","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0026747","article-title":"Status of B-Vitamins and Homocysteine in Diabetic Retinopathy\u202f: Association with Vitamin-B12 Deficiency and Hyperhomocysteinemia","volume":"6","author":"Satyanarayana","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.clnu.2019.01.006_bib36","doi-asserted-by":"crossref","first-page":"79","DOI":"10.4103\/2230-8210.94270","article-title":"Evaluation of serum vitamin B12 levels in type 1 diabetics attending a tertiary care hospital: a preliminary cross \u2013 sectional study","volume":"16","author":"Koshy","year":"2012","journal-title":"Indian J Endocrinol Metab"},{"key":"10.1016\/j.clnu.2019.01.006_bib37","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.biochi.2012.10.028","article-title":"Serum vitamin B12 not reflecting vitamin B12 status in patients with type 2 diabetes","volume":"95","author":"Obeid","year":"2013","journal-title":"Biochimie"},{"key":"10.1016\/j.clnu.2019.01.006_bib38","doi-asserted-by":"crossref","first-page":"5","DOI":"10.12816\/0003082","article-title":"The role of oxidative stress and antioxidants in diabetic complications","volume":"12","author":"Matough","year":"2012","journal-title":"Sultan Qaboos Univ Med J"},{"key":"10.1016\/j.clnu.2019.01.006_bib39","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.numecd.2016.01.006","article-title":"Clinical implications of oxidative stress and potential role of natural antioxidants in diabetic vascular complications","volume":"26","author":"Ceriello","year":"2016","journal-title":"Nutr Metabol Cardiovasc Dis"},{"key":"10.1016\/j.clnu.2019.01.006_bib40","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1002\/jbt.10058","article-title":"Diabetes, oxidative stress, and antioxidants: a review","volume":"17","author":"Maritim","year":"2003","journal-title":"J\u00a0Biochem Mol Toxicol"},{"key":"10.1016\/j.clnu.2019.01.006_bib41","first-page":"1506","article-title":"Diagnosis and treatment of vitamin B12 deficiency. An update","volume":"91","author":"Hvas","year":"2006","journal-title":"Haematologica"},{"key":"10.1016\/j.clnu.2019.01.006_bib42","first-page":"97","article-title":"Optimal management of pernicious anemia","volume":"3","author":"Andres","year":"2012","journal-title":"Hematol Res Rev"},{"issue":"2","key":"10.1016\/j.clnu.2019.01.006_bib43","first-page":"111","article-title":"Oral vitamin B12: a cost-effective alternative","volume":"60","author":"Kolber","year":"2014","journal-title":"Can Fam Physician"},{"key":"10.1016\/j.clnu.2019.01.006_bib44","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1093\/fampra\/cml008","article-title":"Oral vitamin B12 versus intramuscular vitamin B12 for vitamin B12 deficiency: a systematic review of randomized controlled trials","volume":"10","author":"Butler","year":"2006","journal-title":"Fam Pract"},{"key":"10.1016\/j.clnu.2019.01.006_bib45","first-page":"CD004655","article-title":"Oral vitamin B12 versus intramuscular vitamin B12 for vitamin B12 deficiency","volume":"3","author":"Wang","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.clnu.2019.01.006_bib46","doi-asserted-by":"crossref","first-page":"22","DOI":"10.9790\/0853-1509032225","article-title":"Vitamin B12 deficiency in chronic kidney disease","volume":"15","author":"Patil","year":"2016","journal-title":"IOSR-JDMS"},{"key":"10.1016\/j.clnu.2019.01.006_bib47","first-page":"439","article-title":"Clinical use and rational management of homocysteine, folic acid, and B vitamins in cardiovascular and thrombotic diseases","volume":"93","author":"Stanger","year":"2004","journal-title":"Z\u00a0Kardiol"},{"key":"10.1016\/j.clnu.2019.01.006_bib48","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1111\/j.1463-1326.2011.01384.x","article-title":"Emerging role of thiamine therapy for prevention and treatment of early-stage diabetic nephropathy","volume":"13","author":"Rabbani","year":"2011","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.clnu.2019.01.006_bib49","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.2337\/dc09-2241","article-title":"A\u00a0double-blind, randomized, placebo-controlled clinical trial on Benfotiamine treatment in patients with diabetic nephropathy","volume":"33","author":"Alkhalaf","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.clnu.2019.01.006_bib50","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1056\/NEJMe068060","article-title":"Homocysteine trials: clear outcomes for complex reasons","volume":"354","author":"Loscalzo","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clnu.2019.01.006_bib51","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1046\/j.1523-1755.2003.00027.x","article-title":"The AGE inhibitor pyridoxamine inhibits lipemia and development of renal and vascular disease in Zucker obese rats","volume":"63","author":"Alderson","year":"2003","journal-title":"Kidney Int"},{"key":"10.1016\/j.clnu.2019.01.006_bib52","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1681\/ASN.2011111097","article-title":"Pyridoxamine, advanced glycation inhibition, and diabetic nephropathy","volume":"23","author":"Chen","year":"2012","journal-title":"JASN (J Am Soc Nephrol)"},{"key":"10.1016\/j.clnu.2019.01.006_bib53","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.metabol.2006.08.026","article-title":"Effect of pyridoxamine (K-163), an inhibitor of advanced glycation end products, on type 2 diabetic nephropathy in KK-Ay\/Ta mice","volume":"56","author":"Tanimoto","year":"2007","journal-title":"Metab, Clin Exp"},{"key":"10.1016\/j.clnu.2019.01.006_bib54","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.metabol.2006.09.002","article-title":"Vitamin B6 (pyridoxamine) supplementation and complications of diabetes","volume":"56","author":"Jain","year":"2007","journal-title":"Metab, Clin Exp"},{"key":"10.1016\/j.clnu.2019.01.006_bib55","first-page":"263","article-title":"Interaction among dietary vitamin B6, proteins and lipids: effects on liver lipids in rats","volume":"64","author":"Pregnolato","year":"1993","journal-title":"Int J Vitam and Nutr Res. Internationale Zeitschrift Fur Vitamin-Und Ernahrungsforschung. J Int Vitaminologie Nutr"},{"key":"10.1016\/j.clnu.2019.01.006_bib56","first-page":"95","article-title":"The effect of a subnormal dose of vitamin B6 on plasma lipid in the rat","volume":"67","author":"Harripersad","year":"1997","journal-title":"Int JVitam Nutr Res. Internationale Zeitschrift Fur Vitamin-Und Ernahrungsforschung. J Int Vitaminol Nutr"},{"key":"10.1016\/j.clnu.2019.01.006_bib57","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1016\/j.clinthera.2012.06.019","article-title":"Effect of Lysine, Vitamin B6, and Carnitine supplementation on the lipid profile of male patients with hypertriglyceridemia: a 12-week, open-label, randomized, placebo-controlled trial","volume":"34","author":"Hlais","year":"2012","journal-title":"Clin Therapeut"},{"key":"10.1016\/j.clnu.2019.01.006_bib58","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1055\/s-0031-1298016","article-title":"Increased DNA-glycation in type 2 diabetic patients: the effect of thiamine and pyridoxine therapy","volume":"120","author":"Polizzi","year":"2012","journal-title":"Exp Clin Endocrinol Diabetes"}],"container-title":["Clinical Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0261561419300081?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0261561419300081?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,12,27]],"date-time":"2019-12-27T17:33:44Z","timestamp":1577468024000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0261561419300081"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":58,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["S0261561419300081"],"URL":"https:\/\/doi.org\/10.1016\/j.clnu.2019.01.006","relation":{},"ISSN":["0261-5614"],"issn-type":[{"value":"0261-5614","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vitamin B complex supplementation as a homocysteine-lowering therapy for early stage diabetic nephropathy in pediatric patients with type 1 diabetes: A randomized controlled trial","name":"articletitle","label":"Article Title"},{"value":"Clinical Nutrition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clnu.2019.01.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.","name":"copyright","label":"Copyright"}]}}